C Frank Bennett Ionis Pharmaceuticals Inc (IONS) insider trading activity

IONS Quotes by TradingView

C Frank Bennett is EVP, Chief Scientific Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 93,146 shares of IONS, which is worth approximately $3.04 Million. The most recent transaction as insider was on Jan 31, 2025, when has been sold 1,327 shares (Common Stock) at a price of $32.46 per share, resulting in proceeds of $43,074. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.1K
17.01% 3M change
17.79% 12M change
Total Value Held $3.04 Million

C FRANK BENNETT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
SELL
Open market or private sale
$43,074 $32.46 p/Share
1,327 Reduced 1.4%
93,146 Common Stock
Jan 30 2025
BUY
Grant, award, or other acquisition
-
3,607 Added 3.68%
94,473 Common Stock
Jan 16 2025
SELL
Open market or private sale
$222,140 $32.9 p/Share
6,752 Reduced 6.92%
90,866 Common Stock
Jan 15 2025
BUY
Exercise of conversion of derivative security
-
18,011 Added 15.58%
97,618 Common Stock
Aug 30 2024
BUY
Other acquisition or disposition
$6,839 $38.64 p/Share
177 Added 0.22%
79,607 Common Stock
Feb 29 2024
BUY
Other acquisition or disposition
$13,182 $34.42 p/Share
383 Added 0.48%
79,462 Common Stock
Feb 02 2024
SELL
Open market or private sale
$91,760 $49.52 p/Share
1,853 Reduced 2.29%
79,079 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
3,609 Added 4.27%
80,932 Common Stock
Jan 17 2024
SELL
Open market or private sale
$340,082 $50.42 p/Share
6,745 Reduced 8.02%
77,323 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
-
18,314 Added 17.89%
84,068 Common Stock
Dec 21 2023
SELL
Open market or private sale
$794,209 $49.29 p/Share
16,113 Reduced 19.68%
65,754 Common Stock
Dec 21 2023
BUY
Exercise of conversion of derivative security
$762,789 $47.34 p/Share
16,113 Added 16.45%
81,867 Common Stock
Dec 20 2023
SELL
Open market or private sale
$322,660 $49.64 p/Share
6,500 Reduced 9.0%
65,754 Common Stock
Dec 20 2023
BUY
Exercise of conversion of derivative security
$307,710 $47.34 p/Share
6,500 Added 8.25%
72,254 Common Stock
Dec 14 2023
SELL
Open market or private sale
$1,123,816 $49.7 p/Share
22,612 Reduced 25.59%
65,754 Common Stock
Dec 14 2023
BUY
Exercise of conversion of derivative security
$1,070,452 $47.34 p/Share
22,612 Added 23.32%
74,364 Common Stock
Sep 28 2023
SELL
Open market or private sale
$207,390 $46.5 p/Share
4,460 Reduced 6.35%
65,754 Common Stock
Aug 31 2023
BUY
Other acquisition or disposition
$5,500 $30.56 p/Share
180 Added 0.26%
70,214 Common Stock
Feb 28 2023
BUY
Other acquisition or disposition
$11,689 $30.52 p/Share
383 Added 0.54%
70,034 Common Stock
Feb 06 2023
SELL
Open market or private sale
$73,553 $40.57 p/Share
1,813 Reduced 2.54%
69,651 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
3,609 Added 4.81%
71,464 Common Stock
Jan 18 2023
SELL
Open market or private sale
$271,374 $38.89 p/Share
6,978 Reduced 9.32%
67,855 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
19,417 Added 20.6%
74,833 Common Stock
Aug 31 2022
BUY
Other acquisition or disposition
$5,302 $28.97 p/Share
183 Added 0.33%
55,416 Common Stock
Feb 28 2022
BUY
Other acquisition or disposition
$9,816 $28.37 p/Share
346 Added 0.62%
55,233 Common Stock
CFB

C Frank Bennett

EVP, Chief Scientific Officer
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IONS